The latest research study released by Market IntelliX evaluates market size and forecasts of Stroke Therapeutics in Global, including the following market information:

Global Stroke Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Stroke Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Intravenous Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Stroke Therapeutics include Abbott Laboratories, Cordis, Boston Scientific, Siemens, Genentech, Koninklijke Philips, Medtronic, GE Healthcare and Stryker, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MI has surveyed the Stroke Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Market Segmentations:

Global Stroke Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Stroke Therapeutics Market Segment Percentages, by Type, 2021 (%)

Intravenous Injection

Oral

Others

Global Stroke Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Stroke Therapeutics Market Segment Percentages, by Application, 2021 (%)

Ischemic Stroke

Hemorrhagic Stroke

Transient Ischemic Attack

Global Stroke Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Stroke Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Stroke Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Stroke Therapeutics revenues share in global market, 2021 (%)

The report presents profiles of competitors in the market, Some of the prominent key players covered:

Abbott Laboratories

Cordis

Boston Scientific

Siemens

Genentech

Koninklijke Philips

Medtronic

GE Healthcare

Stryker

Merck

Zocere, Inc.

Acticor Biotech

DiaMedica Therapeutics

Lumosa Therapeutics

AXONIS Therapeutics , Inc.

NovaGo Therapeutics

Key Takeaways from this Report

Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.

Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.

Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.

Analyze the sales and distribution channels across key geographies to improve top-line revenues.

Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.

Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.

Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.

1 Introduction to Research & Analysis Reports

1.1 Stroke Therapeutics Market Definition

1.2 Market Segments

1.2.1 Market by Type

1.2.2 Market by Application

1.3 Global Stroke Therapeutics Market Overview

1.4 Features & Benefits of This Report

1.5 Methodology & Sources of Information

1.5.1 Research Methodology

1.5.2 Research Process

1.5.3 Base Year

1.5.4 Report Assumptions & Caveats

2 Global Stroke Therapeutics Overall Market Size

2.1 Global Stroke Therapeutics Market Size: 2021 VS 2028

2.2 Global Stroke Therapeutics Market Size, Prospects & Forecasts: 2017-2028

2.3 Key Market Trends, Opportunity, Drivers and Restraints

2.3.1 Market Opportunities & Trends

2.3.2 Market Drivers

2.3.3 Market Restraints

3 Company Landscape

3.1 Top Stroke Therapeutics Players in Global Market

3.2 Top Global Stroke Therapeutics Companies Ranked by Revenue

3.3 Global Stroke Therapeutics Revenue by Companies

3.4 Top 3 and Top 5 Stroke Therapeutics Companies in Global Market, by Revenue in 2021

3.5 Global Companies Stroke Therapeutics Product Type

3.6 Tier 1, Tier 2 and Tier 3 Stroke Therapeutics Players in Global Market

3.6.1 List of Global Tier 1 Stroke Therapeutics Companies

3.6.2 List of Global Tier 2 and Tier 3 Stroke Therapeutics Companies

4 Market Sights by Product

4.1 Overview

4.1.1 by Type - Global Stroke Therapeutics Market Size Markets, 2021 & 2028

4.1.2 Intravenous Injection

4.1.3 Oral

4.1.4 Others

4.2 By Type - Global Stroke Therapeutics Revenue & Forecasts

4.2.1 By Type - Global Stroke Therapeutics Revenue, 2017-2022

4.2.2 By Type - Global Stroke Therapeutics Revenue, 2023-2028

4.2.3 By Type - Global Stroke Therapeutics Revenue Market Share, 2017-2028

5 Sights by Application

5.1 Overview

5.1.1 By Application - Global Stroke Therapeutics Market Size, 2021 & 2028

5.1.2 Ischemic Stroke

5.1.3 Hemorrhagic Stroke

5.1.4 Transient Ischemic Attack

5.2 By Application - Global Stroke Therapeutics Revenue & Forecasts

5.2.1 By Application - Global Stroke Therapeutics Revenue, 2017-2022

5.2.2 By Application - Global Stroke Therapeutics Revenue, 2023-2028

5.2.3 By Application - Global Stroke Therapeutics Revenue Market Share, 2017-2028

6 Sights by Region

6.1 By Region - Global Stroke Therapeutics Market Size, 2021 & 2028

6.2 By Region - Global Stroke Therapeutics Revenue & Forecasts

6.2.1 By Region - Global Stroke Therapeutics Revenue, 2017-2022

6.2.2 By Region - Global Stroke Therapeutics Revenue, 2023-2028

6.2.3 By Region - Global Stroke Therapeutics Revenue Market Share, 2017-2028

6.3 North America

6.3.1 By Country - North America Stroke Therapeutics Revenue, 2017-2028

6.3.2 US Stroke Therapeutics Market Size, 2017-2028

6.3.3 Canada Stroke Therapeutics Market Size, 2017-2028

6.3.4 Mexico Stroke Therapeutics Market Size, 2017-2028

6.4 Europe

6.4.1 By Country - Europe Stroke Therapeutics Revenue, 2017-2028

6.4.2 Germany Stroke Therapeutics Market Size, 2017-2028

6.4.3 France Stroke Therapeutics Market Size, 2017-2028

6.4.4 U.K. Stroke Therapeutics Market Size, 2017-2028

6.4.5 Italy Stroke Therapeutics Market Size, 2017-2028

6.4.6 Russia Stroke Therapeutics Market Size, 2017-2028

6.4.7 Nordic Countries Stroke Therapeutics Market Size, 2017-2028

6.4.8 Benelux Stroke Therapeutics Market Size, 2017-2028

6.5 Asia

6.5.1 By Region - Asia Stroke Therapeutics Revenue, 2017-2028

6.5.2 China Stroke Therapeutics Market Size, 2017-2028

6.5.3 Japan Stroke Therapeutics Market Size, 2017-2028

6.5.4 South Korea Stroke Therapeutics Market Size, 2017-2028

6.5.5 Southeast Asia Stroke Therapeutics Market Size, 2017-2028

6.5.6 India Stroke Therapeutics Market Size, 2017-2028

6.6 South America

6.6.1 By Country - South America Stroke Therapeutics Revenue, 2017-2028

6.6.2 Brazil Stroke Therapeutics Market Size, 2017-2028

6.6.3 Argentina Stroke Therapeutics Market Size, 2017-2028

6.7 Middle East & Africa

6.7.1 By Country - Middle East & Africa Stroke Therapeutics Revenue, 2017-2028

6.7.2 Turkey Stroke Therapeutics Market Size, 2017-2028

6.7.3 Israel Stroke Therapeutics Market Size, 2017-2028

6.7.4 Saudi Arabia Stroke Therapeutics Market Size, 2017-2028

6.7.5 UAE Stroke Therapeutics Market Size, 2017-2028

7 Players Profiles

7.1 Abbott Laboratories

7.1.1 Abbott Laboratories Corporate Summary

7.1.2 Abbott Laboratories Business Overview

7.1.3 Abbott Laboratories Stroke Therapeutics Major Product Offerings

7.1.4 Abbott Laboratories Stroke Therapeutics Revenue in Global Market (2017-2022)

7.1.5 Abbott Laboratories Key News

7.2 Cordis

7.2.1 Cordis Corporate Summary

7.2.2 Cordis Business Overview

7.2.3 Cordis Stroke Therapeutics Major Product Offerings

7.2.4 Cordis Stroke Therapeutics Revenue in Global Market (2017-2022)

7.2.5 Cordis Key News

7.3 Boston Scientific

7.3.1 Boston Scientific Corporate Summary

7.3.2 Boston Scientific Business Overview

7.3.3 Boston Scientific Stroke Therapeutics Major Product Offerings

7.3.4 Boston Scientific Stroke Therapeutics Revenue in Global Market (2017-2022)

7.3.5 Boston Scientific Key News

7.4 Siemens

7.4.1 Siemens Corporate Summary

7.4.2 Siemens Business Overview

7.4.3 Siemens Stroke Therapeutics Major Product Offerings

7.4.4 Siemens Stroke Therapeutics Revenue in Global Market (2017-2022)

7.4.5 Siemens Key News

7.5 Genentech

7.5.1 Genentech Corporate Summary

7.5.2 Genentech Business Overview

7.5.3 Genentech Stroke Therapeutics Major Product Offerings

7.5.4 Genentech Stroke Therapeutics Revenue in Global Market (2017-2022)

7.5.5 Genentech Key News

7.6 Koninklijke Philips

7.6.1 Koninklijke Philips Corporate Summary

7.6.2 Koninklijke Philips Business Overview

7.6.3 Koninklijke Philips Stroke Therapeutics Major Product Offerings

7.6.4 Koninklijke Philips Stroke Therapeutics Revenue in Global Market (2017-2022)

7.6.5 Koninklijke Philips Key News

7.7 Medtronic

7.7.1 Medtronic Corporate Summary

7.7.2 Medtronic Business Overview

7.7.3 Medtronic Stroke Therapeutics Major Product Offerings

7.7.4 Medtronic Stroke Therapeutics Revenue in Global Market (2017-2022)

7.7.5 Medtronic Key News

7.8 GE Healthcare

7.8.1 GE Healthcare Corporate Summary

7.8.2 GE Healthcare Business Overview

7.8.3 GE Healthcare Stroke Therapeutics Major Product Offerings

7.8.4 GE Healthcare Stroke Therapeutics Revenue in Global Market (2017-2022)

7.8.5 GE Healthcare Key News

7.9 Stryker

7.9.1 Stryker Corporate Summary

7.9.2 Stryker Business Overview

7.9.3 Stryker Stroke Therapeutics Major Product Offerings

7.9.4 Stryker Stroke Therapeutics Revenue in Global Market (2017-2022)

7.9.5 Stryker Key News

7.10 Merck

7.10.1 Merck Corporate Summary

7.10.2 Merck Business Overview

7.10.3 Merck Stroke Therapeutics Major Product Offerings

7.10.4 Merck Stroke Therapeutics Revenue in Global Market (2017-2022)

7.10.5 Merck Key News

7.11 Zocere, Inc.

7.11.1 Zocere, Inc. Corporate Summary

7.11.2 Zocere, Inc. Business Overview

7.11.3 Zocere, Inc. Stroke Therapeutics Major Product Offerings

7.11.4 Zocere, Inc. Stroke Therapeutics Revenue in Global Market (2017-2022)

7.11.5 Zocere, Inc. Key News

7.12 Acticor Biotech

7.12.1 Acticor Biotech Corporate Summary

7.12.2 Acticor Biotech Business Overview

7.12.3 Acticor Biotech Stroke Therapeutics Major Product Offerings

7.12.4 Acticor Biotech Stroke Therapeutics Revenue in Global Market (2017-2022)

7.12.5 Acticor Biotech Key News

7.13 DiaMedica Therapeutics

7.13.1 DiaMedica Therapeutics Corporate Summary

7.13.2 DiaMedica Therapeutics Business Overview

7.13.3 DiaMedica Therapeutics Stroke Therapeutics Major Product Offerings

7.13.4 DiaMedica Therapeutics Stroke Therapeutics Revenue in Global Market (2017-2022)

7.13.5 DiaMedica Therapeutics Key News

7.14 Lumosa Therapeutics

7.14.1 Lumosa Therapeutics Corporate Summary

7.14.2 Lumosa Therapeutics Business Overview

7.14.3 Lumosa Therapeutics Stroke Therapeutics Major Product Offerings

7.14.4 Lumosa Therapeutics Stroke Therapeutics Revenue in Global Market (2017-2022)

7.14.5 Lumosa Therapeutics Key News

7.15 AXONIS Therapeutics , Inc.

7.15.1 AXONIS Therapeutics , Inc. Corporate Summary

7.15.2 AXONIS Therapeutics , Inc. Business Overview

7.15.3 AXONIS Therapeutics , Inc. Stroke Therapeutics Major Product Offerings

7.15.4 AXONIS Therapeutics , Inc. Stroke Therapeutics Revenue in Global Market (2017-2022)

7.15.5 AXONIS Therapeutics , Inc. Key News

7.16 NovaGo Therapeutics

7.16.1 NovaGo Therapeutics Corporate Summary

7.16.2 NovaGo Therapeutics Business Overview

7.16.3 NovaGo Therapeutics Stroke Therapeutics Major Product Offerings

7.16.4 NovaGo Therapeutics Stroke Therapeutics Revenue in Global Market (2017-2022)

7.16.5 NovaGo Therapeutics Key News

8 Conclusion

9 Appendix

9.1 Note

9.2 Examples of Clients

9.3 Disclaimer

List of Tables

Table 1. Stroke Therapeutics Market Opportunities & Trends in Global Market

Table 2. Stroke Therapeutics Market Drivers in Global Market

Table 3. Stroke Therapeutics Market Restraints in Global Market

Table 4. Key Players of Stroke Therapeutics in Global Market

Table 5. Top Stroke Therapeutics Players in Global Market, Ranking by Revenue (2021)

Table 6. Global Stroke Therapeutics Revenue by Companies, (US$, Mn), 2017-2022

Table 7. Global Stroke Therapeutics Revenue Share by Companies, 2017-2022

Table 8. Global Companies Stroke Therapeutics Product Type

Table 9. List of Global Tier 1 Stroke Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share

Table 10. List of Global Tier 2 and Tier 3 Stroke Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share

Table 11. By Type – Global Stroke Therapeutics Revenue, (US$, Mn), 2021 & 2028

Table 12. By Type - Stroke Therapeutics Revenue in Global (US$, Mn), 2017-2022

Table 13. By Type - Stroke Therapeutics Revenue in Global (US$, Mn), 2023-2028

Table 14. By Application – Global Stroke Therapeutics Revenue, (US$, Mn), 2021 & 2028

Table 15. By Application - Stroke Therapeutics Revenue in Global (US$, Mn), 2017-2022

Table 16. By Application - Stroke Therapeutics Revenue in Global (US$, Mn), 2023-2028

Table 17. By Region – Global Stroke Therapeutics Revenue, (US$, Mn), 2021 & 2028

Table 18. By Region - Global Stroke Therapeutics Revenue (US$, Mn), 2017-2022

Table 19. By Region - Global Stroke Therapeutics Revenue (US$, Mn), 2023-2028

Table 20. By Country - North America Stroke Therapeutics Revenue, (US$, Mn), 2017-2022

Table 21. By Country - North America Stroke Therapeutics Revenue, (US$, Mn), 2023-2028

Table 22. By Country - Europe Stroke Therapeutics Revenue, (US$, Mn), 2017-2022

Table 23. By Country - Europe Stroke Therapeutics Revenue, (US$, Mn), 2023-2028

Table 24. By Region - Asia Stroke Therapeutics Revenue, (US$, Mn), 2017-2022

Table 25. By Region - Asia Stroke Therapeutics Revenue, (US$, Mn), 2023-2028

Table 26. By Country - South America Stroke Therapeutics Revenue, (US$, Mn), 2017-2022

Table 27. By Country - South America Stroke Therapeutics Revenue, (US$, Mn), 2023-2028

Table 28. By Country - Middle East & Africa Stroke Therapeutics Revenue, (US$, Mn), 2017-2022

Table 29. By Country - Middle East & Africa Stroke Therapeutics Revenue, (US$, Mn), 2023-2028

Table 30. Abbott Laboratories Corporate Summary

Table 31. Abbott Laboratories Stroke Therapeutics Product Offerings

Table 32. Abbott Laboratories Stroke Therapeutics Revenue (US$, Mn), (2017-2022)

Table 33. Cordis Corporate Summary

Table 34. Cordis Stroke Therapeutics Product Offerings

Table 35. Cordis Stroke Therapeutics Revenue (US$, Mn), (2017-2022)

Table 36. Boston Scientific Corporate Summary

Table 37. Boston Scientific Stroke Therapeutics Product Offerings

Table 38. Boston Scientific Stroke Therapeutics Revenue (US$, Mn), (2017-2022)

Table 39. Siemens Corporate Summary

Table 40. Siemens Stroke Therapeutics Product Offerings

Table 41. Siemens Stroke Therapeutics Revenue (US$, Mn), (2017-2022)

Table 42. Genentech Corporate Summary

Table 43. Genentech Stroke Therapeutics Product Offerings

Table 44. Genentech Stroke Therapeutics Revenue (US$, Mn), (2017-2022)

Table 45. Koninklijke Philips Corporate Summary

Table 46. Koninklijke Philips Stroke Therapeutics Product Offerings

Table 47. Koninklijke Philips Stroke Therapeutics Revenue (US$, Mn), (2017-2022)

Table 48. Medtronic Corporate Summary

Table 49. Medtronic Stroke Therapeutics Product Offerings

Table 50. Medtronic Stroke Therapeutics Revenue (US$, Mn), (2017-2022)

Table 51. GE Healthcare Corporate Summary

Table 52. GE Healthcare Stroke Therapeutics Product Offerings

Table 53. GE Healthcare Stroke Therapeutics Revenue (US$, Mn), (2017-2022)

Table 54. Stryker Corporate Summary

Table 55. Stryker Stroke Therapeutics Product Offerings

Table 56. Stryker Stroke Therapeutics Revenue (US$, Mn), (2017-2022)

Table 57. Merck Corporate Summary

Table 58. Merck Stroke Therapeutics Product Offerings

Table 59. Merck Stroke Therapeutics Revenue (US$, Mn), (2017-2022)

Table 60. Zocere, Inc. Corporate Summary

Table 61. Zocere, Inc. Stroke Therapeutics Product Offerings

Table 62. Zocere, Inc. Stroke Therapeutics Revenue (US$, Mn), (2017-2022)

Table 63. Acticor Biotech Corporate Summary

Table 64. Acticor Biotech Stroke Therapeutics Product Offerings

Table 65. Acticor Biotech Stroke Therapeutics Revenue (US$, Mn), (2017-2022)

Table 66. DiaMedica Therapeutics Corporate Summary

Table 67. DiaMedica Therapeutics Stroke Therapeutics Product Offerings

Table 68. DiaMedica Therapeutics Stroke Therapeutics Revenue (US$, Mn), (2017-2022)

Table 69. Lumosa Therapeutics Corporate Summary

Table 70. Lumosa Therapeutics Stroke Therapeutics Product Offerings

Table 71. Lumosa Therapeutics Stroke Therapeutics Revenue (US$, Mn), (2017-2022)

Table 72. AXONIS Therapeutics , Inc. Corporate Summary

Table 73. AXONIS Therapeutics , Inc. Stroke Therapeutics Product Offerings

Table 74. AXONIS Therapeutics , Inc. Stroke Therapeutics Revenue (US$, Mn), (2017-2022)

Table 75. NovaGo Therapeutics Corporate Summary

Table 76. NovaGo Therapeutics Stroke Therapeutics Product Offerings

Table 77. NovaGo Therapeutics Stroke Therapeutics Revenue (US$, Mn), (2017-2022)

List of Figures

Figure 1. Stroke Therapeutics Segment by Type in 2021

Figure 2. Stroke Therapeutics Segment by Application in 2021

Figure 3. Global Stroke Therapeutics Market Overview: 2021

Figure 4. Key Caveats

Figure 5. Global Stroke Therapeutics Market Size: 2021 VS 2028 (US$, Mn)

Figure 6. Global Stroke Therapeutics Revenue, 2017-2028 (US$, Mn)

Figure 7. The Top 3 and 5 Players Market Share by Stroke Therapeutics Revenue in 2021

Figure 8. By Type - Global Stroke Therapeutics Revenue Market Share, 2017-2028

Figure 9. By Application - Global Stroke Therapeutics Revenue Market Share, 2017-2028

Figure 10. By Region - Global Stroke Therapeutics Revenue Market Share, 2017-2028

Figure 11. By Country - North America Stroke Therapeutics Revenue Market Share, 2017-2028

Figure 12. US Stroke Therapeutics Revenue, (US$, Mn), 2017-2028

Figure 13. Canada Stroke Therapeutics Revenue, (US$, Mn), 2017-2028

Figure 14. Mexico Stroke Therapeutics Revenue, (US$, Mn), 2017-2028

Figure 15. By Country - Europe Stroke Therapeutics Revenue Market Share, 2017-2028

Figure 16. Germany Stroke Therapeutics Revenue, (US$, Mn), 2017-2028

Figure 17. France Stroke Therapeutics Revenue, (US$, Mn), 2017-2028

Figure 18. U.K. Stroke Therapeutics Revenue, (US$, Mn), 2017-2028

Figure 19. Italy Stroke Therapeutics Revenue, (US$, Mn), 2017-2028

Figure 20. Russia Stroke Therapeutics Revenue, (US$, Mn), 2017-2028

Figure 21. Nordic Countries Stroke Therapeutics Revenue, (US$, Mn), 2017-2028

Figure 22. Benelux Stroke Therapeutics Revenue, (US$, Mn), 2017-2028

Figure 23. By Region - Asia Stroke Therapeutics Revenue Market Share, 2017-2028

Figure 24. China Stroke Therapeutics Revenue, (US$, Mn), 2017-2028

Figure 25. Japan Stroke Therapeutics Revenue, (US$, Mn), 2017-2028

Figure 26. South Korea Stroke Therapeutics Revenue, (US$, Mn), 2017-2028

Figure 27. Southeast Asia Stroke Therapeutics Revenue, (US$, Mn), 2017-2028

Figure 28. India Stroke Therapeutics Revenue, (US$, Mn), 2017-2028

Figure 29. By Country - South America Stroke Therapeutics Revenue Market Share, 2017-2028

Figure 30. Brazil Stroke Therapeutics Revenue, (US$, Mn), 2017-2028

Figure 31. Argentina Stroke Therapeutics Revenue, (US$, Mn), 2017-2028

Figure 32. By Country - Middle East & Africa Stroke Therapeutics Revenue Market Share, 2017-2028

Figure 33. Turkey Stroke Therapeutics Revenue, (US$, Mn), 2017-2028

Figure 34. Israel Stroke Therapeutics Revenue, (US$, Mn), 2017-2028

Figure 35. Saudi Arabia Stroke Therapeutics Revenue, (US$, Mn), 2017-2028

Figure 36. UAE Stroke Therapeutics Revenue, (US$, Mn), 2017-2028

Figure 37. Abbott Laboratories Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 38. Cordis Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 39. Boston Scientific Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 40. Siemens Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 41. Genentech Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 42. Koninklijke Philips Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 43. Medtronic Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 44. GE Healthcare Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 45. Stryker Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 46. Merck Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 47. Zocere, Inc. Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 48. Acticor Biotech Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 49. DiaMedica Therapeutics Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 50. Lumosa Therapeutics Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 51. AXONIS Therapeutics , Inc. Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Figure 52. NovaGo Therapeutics Stroke Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)